|NASDAQ: ALHC||Healthcare / Healthcare Plans / USA|
|6.20||+0.0800||+1.31%||Vol 847.64K||1Y Perf -44.16%|
|Mar 24th, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||19.39||Analyst Rating||Moderate Buy 1.59|
|Potential %||212.74||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★ 40.76|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★+ 43.21|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||5.19||Earnings Rating||—|
|Market Cap||1.16B||Earnings Date||4th May 2023|
Today's Price Range
|Moving Averages:||Strong Sell|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th May 2023|
|Estimated EPS Next Report||-0.23|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.17M|
|Avg. Monthly Volume||1.27M|
|Avg. Quarterly Volume||826.00K|
Alignment Healthcare Inc. (NASDAQ: ALHC) stock closed at 6.2 per share at the end of the most recent trading day (a 1.31% change compared to the prior day closing price) with a volume of 847.64K shares and market capitalization of 1.16B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 775 people. Alignment Healthcare Inc. CEO is John E. Kao.
The one-year performance of Alignment Healthcare Inc. stock is -44.16%, while year-to-date (YTD) performance is -47.28%. ALHC stock has a five-year performance of %. Its 52-week range is between 5.49 and 19.17, which gives ALHC stock a 52-week price range ratio of 5.19%
Alignment Healthcare Inc. currently has a PE ratio of -14.20, a price-to-book (PB) ratio of 7.60, a price-to-sale (PS) ratio of 1.85, a price to cashflow ratio of 27.00, a PEG ratio of 2.32, a ROA of -19.59%, a ROC of -28.23% and a ROE of -47.05%. The company’s profit margin is -8.64%, its EBITDA margin is -7.70%, and its revenue ttm is $1.07 Billion , which makes it $5.73 revenue per share.
Of the last four earnings reports from Alignment Healthcare Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. Alignment Healthcare Inc.’s next earnings report date is 04th May 2023.
The consensus rating of Wall Street analysts for Alignment Healthcare Inc. is Moderate Buy (1.59), with a target price of $19.39, which is +212.74% compared to the current price. The earnings rating for Alignment Healthcare Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Alignment Healthcare Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Alignment Healthcare Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 61.10, ATR14 : 0.50, CCI20 : -52.75, Chaikin Money Flow : -0.17, MACD : -1.08, Money Flow Index : 28.12, ROC : -9.88, RSI : 29.34, STOCH (14,3) : 42.01, STOCH RSI : 1.00, UO : 46.14, Williams %R : -57.99), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Alignment Healthcare Inc. in the last 12-months were: Dawn Maroney (Sold 144 409 shares of value $1 866 507 ), Dinesh Kumar (Sold 262 451 shares of value $3 669 656 ), Donald Furman (Sold 3 006 shares of value $33 594 ), Jeffrey H. Margolis (Sold 1 200 shares of value $21 600 ), John E. Kao (Sold 807 758 shares of value $12 196 880 ), Joseph Konowiecki (Buy at a value of $661 610), Richard A. Cross (Sold 7 108 shares of value $52 691 ), Robert Thomas Freeman (Sold 162 216 shares of value $2 230 108 )
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Strong Buy||Strong Buy||Strong Buy|
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which they receive healthcare coverage and services on an annual basis.
CEO: John E. Kao
Telephone: +1 844 310-2247
Address: 1100 W. Town and Country Road, Orange 92868, CA, US
Number of employees: 775
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.